Christopher Lischer
Overview
Explore the profile of Christopher Lischer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Biedermann A, Patra-Kneuer M, Mougiakakos D, Buttner-Herold M, Mangelberger-Eberl D, Berges J, et al.
Haematologica
. 2024 Jun;
109(12):3928-3940.
PMID: 38934068
Macrophages are one of the key mediators of the therapeutic effects exerted by monoclonal antibodies, such as the anti-CD19 antibody tafasitamab, approved in combination with lenalidomide for the treatment of...
2.
Lischer C, Eberhardt M, Flamann C, Berges J, Guse E, Wessely A, et al.
J Immunother Cancer
. 2024 May;
12(5).
PMID: 38724462
Background: Tumor-associated antigens and their derived peptides constitute an opportunity to design off-the-shelf mainline or adjuvant anti-cancer immunotherapies for a broad array of patients. A performant and rational antigen selection...
3.
Winter S, Schneider M, Oelschlaegel U, Maggioni G, Riva E, Raddi M, et al.
Leukemia
. 2024 Apr;
38(6):1427-1431.
PMID: 38632316
No abstract available.
4.
Lischer C, Bruns H
Cell Rep Med
. 2023 Oct;
4(10):101237.
PMID: 37852178
In their article, Cheng et al. reveal that NEK2 loss reshapes the tumor microenvironment, reducing tumor-associated macrophages and decreasing T cell exhaustion. They show that this ultimately favors the immune...
5.
Vera J, Lai X, Baur A, Erdmann M, Gupta S, Gutta C, et al.
Brief Bioinform
. 2022 Oct;
23(6).
PMID: 36252807
We live in an unprecedented time in oncology. We have accumulated samples and cases in cohorts larger and more complex than ever before. New technologies are available for quantifying solid...
6.
Reimann H, Kremer A, Blumenberg V, Schmidt K, Aigner M, Jacobs B, et al.
Blood Adv
. 2022 Oct;
7(10):2066-2069.
PMID: 36206194
No abstract available.
7.
Sauerer T, Lischer C, Weich A, Berking C, Vera J, Dorrie J
Front Microbiol
. 2022 Jan;
12:785662.
PMID: 35003017
Merkel cell carcinoma (MCC) is a rare and highly aggressive cancer, which is mainly caused by genomic integration of the Merkel cell polyomavirus and subsequent expression of a truncated form...
8.
Mougiakakos D, Bach C, Bottcher M, Beier F, Rohner L, Stoll A, et al.
Cancer Immunol Res
. 2021 Feb;
9(3):265-278.
PMID: 33563611
The bone marrow niche has a pivotal role in progression, survival, and drug resistance of multiple myeloma cells. Therefore, it is important to develop means for targeting the multiple myeloma...
9.
Vera J, Lischer C, Nenov M, Nikolov S, Lai X, Eberhardt M
Int J Mol Sci
. 2021 Jan;
22(2).
PMID: 33430432
In most disciplines of natural sciences and engineering, mathematical and computational modelling are mainstay methods which are usefulness beyond doubt. These disciplines would not have reached today's level of sophistication...
10.
Lai X, Dreyer F, Cantone M, Eberhardt M, Gerer K, Jaitly T, et al.
Theranostics
. 2021 Jan;
11(3):1412-1428.
PMID: 33391542
Dendritic cells (DCs) are professional antigen-presenting cells that induce and regulate adaptive immunity by presenting antigens to T cells. Due to their coordinative role in adaptive immune responses, DCs have...